<DOC>
	<DOCNO>NCT01240512</DOCNO>
	<brief_summary>This randomize , double-blind , multicenter , 6-month follow-up trial low ( 400 IU/day ) versus high ( 4000 IU/day ) dose vitamin D supplementation individual pre- early stage 1 hypertension vitamin D deficiency . A total 530 participant ( 265 participant per treatment arm ) randomize 3 site . Approximately 2,250 participant screen 3 site . Vital sign , 24-hour ambulatory blood pressure monitoring , clinical laboratory safety test adverse event assessment perform evaluate effectiveness two dos vitamin D blood pressure . Blood sample store future biomarker assessment . The total duration study anticipate 18 month , assume 12 month enrollment period .</brief_summary>
	<brief_title>DAYLIGHT : Vitamin D Therapy Individuals High Risk Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Vitamin D Deficiency</mesh_term>
	<mesh_term>Prehypertension</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>Males females 18 50 year age Systolic blood pressure 120 159 mmHg Diastolic blood pressure â‰¤99 mmHg Vitamin D deficiency , define 25hydroxyvitamin D &lt; 25 ng/ml No use antihypertensive medication last 3 month anticipate plan use next 6 month No use vitamin D supplementation last 3 month , define vitamin D find multivitamin supplement total &gt; 400 IU per day anticipate plan use next 6 month Use antihypertensive medication last 3 month anticipate plan use next 6 month Use vitamin D supplementation last 3 month , define vitamin D find multivitamin supplement total &gt; 400 IU per day anticipate plan use next 6 month Use St. John 's wart , rifampin , treatment HIV , orlistat , oral glucocorticoid , phenobarbital , phenytoin , mineral oil , bile acid sequestrants last 3 month anticipate plan use next 6 month Female pregnant , nursing , childbearing potential planning anticipate pregnancy next 6 month History diabetes mellitus ( include Type 1 , Type 2 diet control ) Serum creatinine &gt; 2.0 mg/dl estimate Glomerular Filtration Rate ( GFR ) &lt; 30 ml/min Calcium &gt; 10.0 mg/dl phosphorus &gt; 5 mg/dl History kidney stone Body mass index &gt; 38 kg/m2 Known cardiovascular disease : define prior myocardial infarction , percutaneous transluminal coronary angioplasty , coronary artery bypass stroke History cirrhosis severe liver disease ( defined history GI bleeding liver disease , jaundice ascites ) Current heavy alcohol use : define drink 5 drink per occasion 5 day past 30 day History ulcerative colitis , Crohn 's disease , celiac disease , colostomy , pancreatic enzyme deficiency , short bowel syndrome , gastric bypass , cystic fibrosis , dump syndrome . Allergy coconut Regular use plan use artificial tan light next 6 month Use investigational product device last 3 month plan use next 6 month Any condition could limit ability complete comply 6month follow Unwillingness inability comply study requirement Inability provide inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>